Postoperative Impact of Anti‐Inflammatory Drug on Cancer Recurrence in Patients With Locally Advanced Gastric Cancer After Curative Gastrectomy: A Pilot Retrospective Study
Anti-inflammatory drug administration after radical resection may prolong recurrence-free survival in patients with pStage III gastric cancer.
Authors
- Tomoyuki Irino (ORCID: https://orcid.org/0000-0002-2056-0721)
- Souya Nunobe (ORCID: https://orcid.org/0000-0003-3012-5632)
- Rie Makuuchi (ORCID: https://orcid.org/0000-0002-7186-6181)
- Masaru Hayami (ORCID: https://orcid.org/0000-0003-3460-3785)
- Ryota Matsui (ORCID: https://orcid.org/0000-0003-0541-2357)
- Manabu Ohashi (ORCID: https://orcid.org/0000-0001-7417-3682)
- Takeshi Sano
- Motonari Ri (ORCID: https://orcid.org/0000-0001-8103-9721)
Institutions
- Kanazawa University (JP)
- The Cancer Institute Hospital (JP)
- Japanese Foundation For Cancer Research (JP)
Publication Details
- Journal
- Annals of Gastroenterological Surgery
- Published
- 2025-10-12
- DOI
- https://doi.org/10.1002/ags3.70110
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00